Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Contact Information
Affiliated Doctors
Duke Comprehensive Cancer Center proudly enjoys its designation as an NCI Comprehensive Cancer Center. Obtaining this honor is no small feat. To earn this distinction, cancer centers must meet strict requirements to provide complete cancer care. This includes preventative education, diagnostics, treatment and research activities that are above and beyond normal service to the public and those patients with all types of cancer.
Located at Duke University in Durham, North Carolina, the Duke Comprehensive Cancer Center has a mission to “extend and improve the quality of life” for cancer patients, their families and to provide a solid educational contribution to the public and students. The Duke CCC cares for over 7,000 new cancer patients annually. Patients receive the benefit of extensive experience and research into common cancers, as well as less common like mesothelioma.
Duke Comprehensive Cancer Center is staffed by expert physicians who have national recognition for their work with cancer. This center, according to U.S. News & World Report’s survey of “America’s Best Hospitals,” ranks in the top ten cancer hospitals in America and number one in the South. It is known for having outstanding programs targeting all cancers. Physicians, surgeons, scientists, researchers, nurses and clinical specialists work as a team to make this center the best choice for cancer patients. Patients receive compassionate, individualized treatment programs specific to their cancer.
Duke CCC receives over 9,000 inpatients and another 218,000 outpatients annually. Over 120 chemotherapy patients are seen daily. The reputation of this center is so well known and publicized that around 20% of these patients are from areas outside of the state.
Clinical trials and specialized research are top priorities at this center. The Hereditary Cancer Clinic at Duke CCC focuses on cancer risks for persons who have family histories of cancer diseases. Assessment, education and research projects add to understanding the importance of genetics and cancer. Board-certified genetic teams counsel patients about their possible genetic risks for cancer and why early detection is important.
Clinical trials are important to researchers for developing new methods of preventing, discovering and treating all types of cancer. The center draws on experts in medicine and research from affiliate groups and the Duke University Medical Center to offer at least 250 clinical trials every year. Expertise at all affiliated groups is enhanced by the range of scientific research and experience held by the total of all members in all groups. New ideas, theories, technological developments and treatment approaches are developed quickly within this extended group of experts.
Another aspect of cancer care in which the Duke Comprehensive Cancer Center excels is patient support and follow-up care. The center is part of the Duke Oncology Network, which is a community outreach consortium made up of many affiliated cancer practices in the southeastern United States.
In addition to their Cancer Patient Support Program, Duke CCC offers an Oncology Recreation Therapy Program. Another focus of comprehensive care is directed to children and young adults. At Duke University Medical Center, the Division of Pediatric Hematology-Oncology has many programs and treatment approaches specifically tailored to the needs of youth with cancer. This includes new research techniques of bone marrow, cord blood therapies and stem cell research studies. Clinical trials are also available for children and young adult participation.
Cancer survivors who are in remission or recovery have the Duke CCC Long-Term Cancers Survivors Program to support them with an ongoing care program. Children and young adults comprise the majority of patients in these programs.